Elderly Clinical Trial
Official title:
Safety and Efficacy of Allogeneic NK Cell Therapy for Recurrent/Refractory Elderly AML
The aim of this investigation was to assess safety and efficacy of allogenic NK cells therapy for recurrent refractory elderly AML.
Status | Not yet recruiting |
Enrollment | 10 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. The 2 or more than 2-cycles of standard regimen was used to treat elderly AML patients who did not achieve complete remission or relapse. 2. Patients with age 60 years to 70 years. 3. KPS greater than or equal to 60. 4. ALT and AST are less than 3 times normal. 5. Total bilirubin less than 1.5mg/dl(25.65umol/L). 6. Serum creatinine less than 2.5mg/dl(221umol/L), or creatinine scavenging ability greater than or equal to 60 mL/min/1.73 m2. 7. Left ventricular ejection fraction cardiac greater than or equal to 45%, Echocardiography (ECHO) showed no pericardial effusion, Electrocardiogram (ECG) is normal. 8. No pleural effusion in lungs 9. Oxyhemoglobin saturation greater than or equal to 92% in normal environment. 10. KIR mismatch between patient and umbilical cord blood. 11. Volunteer to participate in the trial and sign the informed consent form. Exclusion Criteria: 1. Malignant tumor patient. 2. Patients who are accompanied by fungal, bacterial, viral, or other uncontrolled infections or require level 4 isolation( HBV-DNA quantification and normal liver function in patients with hepatitis b infection are excluded). 3. Patients with HIV, HCV positive. 4. Patients with central nervous system diseases, including stroke, epilepsy, dementia, or autoimmune central nervous system disorders. 5. During the first 12 months of enrollment, patients with cardioangiography or stents, active angina pectoris or other clinically significant symptoms, or with cardiogenic asthma. 6. Patients receiving anticoagulant therapy or with severe coagulation disorders. 7. According to the researcher's judgment, the drug treatment the patient is receiving will affect the safety and effectiveness of the study. 8. Patients with allergies or history of allergies to biological agents used in this program. 9. Systemic steroid used within 2 weeks before treatment (except for recent or present use of inhaled corticosteroids). 10. Patients with other uncontrolled diseases, Investigators think it is not suitable for the participants. 11. Any circumstance that the investigator considers may increase the risk to the subject or interfere with the results of the study. 12. Patients participate in other clinical studies. |
Country | Name | City | State |
---|---|---|---|
China | The 2nd Hospital of Shandong University | Jinan | Shandong |
Lead Sponsor | Collaborator |
---|---|
The Second Hospital of Shandong University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective Response Rate (ORR) (PR+CR) | The proportion of patients with complete response(CR) or partial response(PR) as measured by response criteria definitions for acute myeloid leukemia | 3 months | |
Secondary | Overall survival(OS) | The proportion of patients with overall survival(OS). | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05531396 -
Agility Training on Physical Performance, Cognitive Function and Brain Activities in Elderly
|
N/A | |
Completed |
NCT03580447 -
The Effect of Citrus Extract on Oxidative Stress
|
N/A | |
Recruiting |
NCT04096547 -
Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
|
||
Completed |
NCT03339791 -
Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT03566719 -
Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults
|
N/A | |
Completed |
NCT02138968 -
Clinical and Economic Assessment of a Pre-frail Screening Program
|
N/A | |
Completed |
NCT01368029 -
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
|
Phase 1 | |
Not yet recruiting |
NCT01182961 -
The Use of Virtual Reality for the Gait Training of Elderly Fallers
|
N/A | |
Completed |
NCT00961012 -
The Big Squeeze (Lessening the Big Squeeze: The Effect of the Trunk Release on Interface Pressures of Individuals Seated in a High Fowler's Positions)
|
N/A | |
Completed |
NCT01899586 -
Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly
|
N/A | |
Completed |
NCT00748683 -
Development of an Integrated Health Care Environment for Elderly With RFID Technology
|
Phase 0 | |
Completed |
NCT00533065 -
Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
|
N/A | |
Completed |
NCT00798668 -
The Body's Response to Food Intake in Trained, Older Adults
|
N/A | |
Completed |
NCT00324701 -
Telepsychology-Service Delivery for Depressed Elderly Veterans
|
N/A | |
Completed |
NCT00217113 -
An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly
|
N/A | |
Completed |
NCT03666793 -
Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care
|
N/A | |
Recruiting |
NCT06030804 -
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
|
N/A | |
Recruiting |
NCT05014750 -
Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
|
||
Completed |
NCT05021432 -
Virtual Reality And Task Oriented Circuit Training Among Elderly Population
|
N/A | |
Active, not recruiting |
NCT04132492 -
AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients
|